Loading…
Touchlight manufactures high-purity, cell-free DNA using its proprietary dbDNA™ technology, offering scalable solutions from research use only to GMP grade. The company's mbDNA™ platform provides a circular single-stranded DNA molecule designed to enable better non-viral gene therapy and gene editing applications.
AI named Touchlight from February 2026 to March 2026.